Publikationen (35) Publikationen, an denen Forscher/innen teilgenommen haben

2012

  1. Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class

    Clinical Microbiology and Infection, Vol. 18, Núm. 11

  2. Antiphospohlipid syndrome in obstetrics

    Best Practice and Research: Clinical Obstetrics and Gynaecology, Vol. 26, Núm. 1, pp. 65-76

  3. Cardiac valve replacement in patients with antiphospholipid syndrome

    Arthritis Care and Research, Vol. 64, Núm. 8, pp. 1256-1260

  4. Clinical score for the outcome of external cephalic version: A two-phase prospective study

    Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 52, Núm. 1, pp. 59-61

  5. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  6. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial

    Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968

  7. Derivation and validation of a clinical prediction rule for delirium in patients admitted to a medical ward: An observational study

    BMJ Open, Vol. 2, Núm. 5

  8. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 64, Núm. 8, pp. 2677-2686

  9. Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.)

    Nefrologia, Vol. 32, Núm. SUPPL. 1, pp. 1-45

  10. Diagnóstico y tratamiento de la nefritis lúpica: El camino del consenso

    Revista Clinica Espanola, Vol. 212, Núm. 3, pp. 155-156

  11. Direct testing of bronchoalveolar lavages from ventilator-associated pneumonia patients

    Diagnostic Microbiology and Infectious Disease, Vol. 73, Núm. 2, pp. 107-110

  12. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  13. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

    Autoimmunity Reviews, Vol. 11, Núm. 5, pp. 357-364

  14. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy

    Antiviral Therapy, Vol. 17, Núm. 3, pp. 577-583

  15. Glucocorticoid use and abuse in SLE

    Rheumatology (United Kingdom), Vol. 51, Núm. 7, pp. 1145-1153

  16. Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis

    Journal of Infection, Vol. 64, Núm. 2, pp. 204-211

  17. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients

    Hepatology, Vol. 56, Núm. 4, pp. 1261-1270

  18. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

    AIDS, Vol. 26, Núm. 15, pp. 1917-1926

  19. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'

    Autoimmunity Reviews, Vol. 11, Núm. 8, pp. 577-580

  20. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

    BMC Infectious Diseases, Vol. 12